Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
1:00:58
Updates from the 2023 ASH Meeting
56:26
Navigating the 2024 PAD Guidelines
1:00:08
Women’s Health Considerations in Thrombosis Webinar
59:40
Understanding the 2023 ACR/EULAR APS Classification Criteria
1:03:23
Anticoagulation for AF, VTE and PVT in Cirrhosis
1:01:24
DOACs and Kidney Dysfunction
1:00:34